Insulin Pump Market Size 2021 is Projected to Reach USD 11.86 Billion by 2028, Exhibiting a CAGR of 16.0%

 Insulin pumps are compact electronic medical devices that can be fastened to a belt, hidden in a pocket, or worn under clothing. The pump is used to deliver controlled quantities of insulin into the body at regular intervals, based on the user's basal and bolus rates, to keep blood glucose levels from becoming too high. It works by inserting insulin directly into the fatty tissue using a needle and a flexible catheter, which is subsequently taped and fixed in place. Insulin pumps help people with type 1 and type 2 diabetes by allowing them more freedom in their food choices and eating patterns, as well as reducing the number of injections they need.



The rising prevalence of diabetes around the world, as well as rising health awareness, are driving market expansion. The frequency of various lifestyle diseases, particularly diabetes, has increased considerably as economies have modernized. Changes in dietary habits, as well as a reliance on ready-to-eat commercial foods containing artificial additives and preservatives, exacerbate the problem. Because diabetes can lead to other chronic illnesses including kidney failure, stroke, paralysis, and blindness, manufacturers are focusing more on developing adaptable and affordable equipment.

The demand for efficient insulin pumps has also increased as a result of the development of very accurate glucose sensors and blood monitoring systems. Furthermore, market expansion has been aided by factors such as rising per capita healthcare spending and increased research & development to improve the functionality of insulin pumps.

Note: Insulin Pump Market Size 2021 is Projected to Reach USD 11.86 Billion by 2028, Exhibiting a CAGR of 16.0%


The onset of Diabetes in Recovering COVID-19 Patients May Favor Market Growth

While there is evidence that diabetics have a higher risk of COVID-19 infection, the current study has discovered that recovered coronavirus patients have a higher risk of acquiring diabetes due to reduced organ function. COVID-19 non-diabetic survivors have a 39 percent greater risk of acquiring diabetes within six months after infection, according to a research team from Missouri's Veterans Affairs St. Louis Health Care System in May 2021. A group of academics from the Office of National Statistics in the United Kingdom, the University of Leicester in the United Kingdom, University College London, and Roy Morgan Research published similar findings. Coronavirus patients have a 50% higher chance of developing diabetes within 20 weeks of discharge, according to this study. As a result of the intricate relationship between diabetes and COVID-19, demand for effective diabetes management devices is projected to rise, with insulin pumps leading the trend.

Despite these ideal circumstances, the growth of the insulin pump market is anticipated to be stifled due to the COVID-19 pandemic, as hospitals, clinics, and health professionals devote all of their resources to treating coronavirus patients. As a result, non-essential procedures have been postponed, potentially harming this market. The insulin pump market will increase at a slower rate of 11.7 percent in 2020 and it is expected to reach USD 4.13 billion in 2021.




Comments

Popular posts from this blog

Continuous Glucose Monitoring (CGM) Devices Market -Dynamics and Forecast

YOU YES YOU!

Key Benefits of Breath Analyzer Market